Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Solute carrier family 25 member 6 pseudogene" (LOC100422685; ENSG00000271339) is a pseudogene related to the SLC25A6 gene, which encodes a mitochondrial ADP/ATP translocase (adenine nucleotide translocator); pseudogenes do not produce functional proteins and are not considered drug targets[1][3][4]. There is no evidence it performs any biological function or disease role, is not targeted by drugs, and lacks a canonical abbreviation. Its only relevant classification is as a pseudogene, and not a transporter, receptor, enzyme or therapeutic target. **Key context:** - This entry is classified as a **pseudogene**, which by definition does not encode a functional protein and is not considered a valid therapeutic target[3][4]. - The functional gene (SLC25A6) is important in mitochondrial transport and apoptosis, but this does *not* apply to the pseudogene variant you queried; all gene function, pathway, or disease associations cited for "SLC25A6" do *not* apply to this pseudogene. - There are multiple related pseudogenes cataloged (e.g., SLC25A6P1, SLC25A6P4, SLC25A6P6)[2][4][5][6], all nonfunctional copies. - It is sometimes indexed under alternative locations or IDs, notably "LOC100422685" and "ENSG00000271339". - If you meant the **functional SLC25A6 gene (adenine nucleotide translocator 3)**, not the pseudogene, you should clarify, as that is a validated transporter protein and sometimes a therapeutic target in mitochondrial biology[3][7]. **This target is not suited for therapeutic targeting or structured data extraction except as a pseudogene (nonfunctional DNA locus).**
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 member 6 pseudogene.